10-Q: Cardlytics Reports Q3 2024 Results, Faces Goodwill Impairment
Quarterly Report
Cardlytics' Q3 2024 results reveal a significant goodwill impairment charge impacting overall profitability, despite some growth in user base.
Summary
- Cardlytics reported a net loss of $145.2 million for the third quarter of 2024, compared to a net loss of $24 million in the same period last year.
- The company's revenue decreased by 15% to $67.1 million in Q3 2024, down from $79 million in Q3 2023.
- Billings decreased by 4% to $112 million in Q3 2024, compared to $116.4 million in Q3 2023.
- A significant goodwill impairment charge of $117.8 million related to the Bridg platform contributed to the substantial net loss.
- The company's monthly active users (MAUs) increased by 2% to 166.4 million in Q3 2024, compared to 162.5 million in Q3 2023.
- Average revenue per user (ARPU) decreased by 18% to $0.40 in Q3 2024, compared to $0.49 in Q3 2023.
- For the nine months ended September 30, 2024, the net loss was $173.7 million, compared to a net loss of $33.9 million in the same period last year.
- The company's revenue decreased by 7% to $204.3 million for the nine months ended September 30, 2024, down from $220 million in the same period last year.
- Billings increased by 2% to $327.6 million for the nine months ended September 30, 2024, compared to $321.5 million in the same period last year.
- The company completed an at-the-market offering program, selling 3.9 million shares for net proceeds of $48.3 million.
- Cardlytics issued $172.5 million in convertible senior notes and used a portion of the proceeds to repurchase $183.9 million of existing notes.
Sentiment
Score: 3
Explanation: The document presents a negative outlook due to significant losses, revenue decline, and a large goodwill impairment. While there are some positives like user growth and capital raising, the overall tone is concerning from an investment perspective.
Positives
- Cardlytics' monthly active users (MAUs) increased by 2% in Q3 2024, indicating some growth in user engagement.
- The company successfully completed an at-the-market offering program, raising $48.3 million in net proceeds.
- Cardlytics issued $172.5 million in convertible senior notes, which provides additional capital.
- The company repurchased $183.9 million of existing convertible notes, reducing its debt obligations.
Negatives
- Cardlytics reported a substantial net loss of $145.2 million in Q3 2024, primarily due to a significant goodwill impairment.
- The company's revenue decreased by 15% in Q3 2024, indicating a decline in sales.
- Billings decreased by 4% in Q3 2024, suggesting a slowdown in business activity.
- Average revenue per user (ARPU) decreased by 18% in Q3 2024, indicating lower revenue generation per user.
- The company recognized an acquired intangible asset impairment of $13.7 million during the three months ended September 30, 2024.
Risks
- The company's business is subject to risks related to unfavorable economic conditions, which could limit growth and negatively affect operating results.
- Cardlytics' quarterly operating results have fluctuated and may continue to vary, which could cause the stock price to decline.
- The company may not be able to sustain its revenue and billings growth rate in the future.
- Cardlytics is dependent on the Cardlytics platform and may face challenges if it fails to adapt to changing technology and industry needs.
- The company is substantially dependent on a limited number of financial institution partners.
- Cardlytics faces competition in the market and may not be able to compete successfully.
- Servicing the company's debt may require a significant amount of cash, and it may not have sufficient cash flow to pay its indebtedness.
- The company is subject to stringent and changing privacy and data security laws, and failure to comply could lead to regulatory actions and litigation.
- Failure to protect proprietary technology and intellectual property rights could harm the business.
- The market price of the company's common stock is likely to continue to be volatile.
- Anti-takeover provisions could make an acquisition of the company more difficult.
Future Outlook
The company expects to incur additional operating losses in the near term as it continues to grow its business and may require additional capital resources to continue to grow its business.
Industry Context
The report highlights the challenges faced by companies in the purchase intelligence and digital advertising space, particularly in the current economic environment. The goodwill impairment suggests a reevaluation of the value of acquisitions in this sector. The company's reliance on a few key financial institution partners also underscores the importance of strategic partnerships in this industry.
Comparison to Industry Standards
- The significant goodwill impairment charge of $117.8 million is a notable deviation from industry norms, suggesting a potential overvaluation of the Bridg platform acquisition.
- The decrease in revenue and billings, coupled with a decline in ARPU, indicates that Cardlytics is underperforming compared to some of its peers in the digital advertising space.
- While the increase in MAUs is a positive sign, the decrease in ARPU suggests that the company is struggling to monetize its user base effectively.
- The company's reliance on a few key financial institution partners is a common risk in the industry, but the concentration of over 95% of Partner Share with the top three partners is higher than some competitors.
- The company's debt levels, including the convertible senior notes, are higher than some of its peers, which could pose a risk in a rising interest rate environment.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | NA | Amit Gupta | 2024-08-16 | New appointment |
Legal Proceedings
- The company is not presently a party to any legal proceedings that, if determined adversely to it, would individually or taken together have a material adverse effect on its business, operating results, financial condition or cash flows.
Stakeholder Impact
- Shareholders will be negatively impacted by the significant net loss and the decline in stock price.
- Employees may face uncertainty due to the company's financial challenges.
- Customers may be concerned about the company's ability to provide reliable services.
- Suppliers and creditors may face increased risk due to the company's financial situation.
Next Steps
- The company will need to focus on improving revenue generation and profitability.
- Cardlytics will need to manage its debt obligations effectively.
- The company will need to address the issues that led to the goodwill impairment.
- Cardlytics will need to continue to innovate and adapt to changing market conditions.
Key Dates
| Date | Description |
|---|---|
| 2020-09-22 | Issued $230 million in convertible senior notes due in September 2025. |
| 2023-12-07 | Sold and transferred substantially all of the assets of HSP EPI Acquisition, LLC. |
| 2024-01-25 | Entered into a settlement agreement with the Stockholder Representative to resolve disputes related to the Bridg acquisition. |
| 2024-01-29 | Filed a shelf registration statement on Form S-3 with the SEC. |
| 2024-02-09 | Shelf registration statement declared effective by the SEC. |
| 2024-03-18 | Entered into an equity distribution agreement for at-the-market offerings. |
| 2024-04-01 | Issued $172.5 million in convertible senior notes due in 2029. |
| 2024-06-10 | PNC Financial Services Group, Inc. transferred $5.9 million to Cardlytics from a payment account related to the Bridg acquisition. |
| 2024-09-30 | End of the quarterly period for which the report was filed. |
| 2024-10-31 | 50,822,443 shares of common stock outstanding. |
Keywords
Cardlytics, goodwill impairment, revenue, billings, MAUs, ARPU, convertible notes, at-the-market offering, financial results, debt, Bridg platform, financial institutions, marketing, advertising, data security, intellectual property
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.